pirenzepine has been researched along with Learning Disabilities in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, Y | 1 |
| Zhao, Q | 1 |
| Harada, K | 1 |
| Tohda, M | 1 |
| Watanabe, H | 1 |
| Matsumoto, K | 1 |
| Ukai, M | 1 |
| Itoh, J | 1 |
| Kobayashi, T | 1 |
| Shinkai, N | 1 |
| Kameyama, T | 1 |
2 other studies available for pirenzepine and Learning Disabilities
| Article | Year |
|---|---|
Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.
Topics: Acetylcholine; Aggression; Alkaloids; Animals; Arterial Occlusive Diseases; Avoidance Learning; Beha | 2005 |
Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Topics: Analgesics, Opioid; Animals; Dynorphins; Injections, Intraventricular; Learning; Learning Disabiliti | 1997 |